Showing 1 - 10 of 15
Persistent link: https://www.econbiz.de/10005757614
Persistent link: https://www.econbiz.de/10005613298
The odds ratio (OR) has been recommended elsewhere to measure the relative treatment efficacy in a randomized clinical trial (RCT), because it possesses a few desirable statistical properties. In practice, it is not uncommon to come across an RCT in which there are patients who do not comply...
Persistent link: https://www.econbiz.de/10008773833
The proportion ratio (PR) of patient response is one of the most commonly used indices for measuring the relative treatment effect in a randomized clinical trial (RCT). Assuming a random effect multiplicative risk model, we develop two point estimators and three interval estimators in closed...
Persistent link: https://www.econbiz.de/10010574453
Persistent link: https://www.econbiz.de/10010947816
Persistent link: https://www.econbiz.de/10010948287
When assessing a treatment effect in the presence of confounders, we often employ stratified analysis and obtain a summary estimate of the risk difference (RD) under the assumption that the underlying RD is homogeneous across strata. In a randomized clinical trial (RCT), we may commonly come...
Persistent link: https://www.econbiz.de/10005130645
Persistent link: https://www.econbiz.de/10005130657
When measuring the efficacy of an experimental treatment in dichotomous data, we often employ the proportion ratio () of a positive response (or an adverse event) between the experimental and standard treatments. In this paper, we consider a non-compliance randomized clinical trial with outcomes...
Persistent link: https://www.econbiz.de/10005165703
When comparing an experimental treatment with a standard treatment in a randomized clinical trial (RCT), we often use the risk difference (RD) to measure the efficacy of an experimental treatment. In this paper, we have developed four asymptotic interval estimators for the RD in a stratified RCT...
Persistent link: https://www.econbiz.de/10005172400